What the changes say
- APM acquisition adds exposure to ITAR, EAR, sanctions, and U.S. government-contracting requirements.
- Customer concentration remains extreme: largest customer rose to 78% of sales, while top-three concentration declined to 92%.
- The largest customer’s surgical-handpiece commitments now extend through 2028, versus 2025 previously.
- Previously disclosed internal-control weaknesses and remediation costs are no longer listed; accounting-standards risk is substantively unchanged.
What changed since the prior 10-K
New
- NewRegulatory & Compliance Risks
Our acquisition of APM may increase our exposure to complex export control and government contracting requirements, the violation of which could have a material adverse effect on our business
APM exposes the company to complex ITAR, EAR, sanctions, and U.S. government-contracting requirements for aerospace and defense work.
Dropped
- DroppedRegulatory & Compliance Risks
We have previously identified material weaknesses in our internal control over financial reporting. Failure to achieve and maintain effective internal control over financial reporting could materially and adversely affect our business, results of operations, financial condition, and stock price
- DroppedRegulatory & Compliance Risks
Our evaluation of internal controls and remediation of potential problems is costly and time-consuming and could expose weaknesses in financial reporting
Reworded
- 67% rewrittenRegulatory & Compliance Risks
We are subject to changes in and interpretations of financial accounting matters that govern the measurement of our performance, compliance with which could be costly and time-consuming
The accounting-standards risk text is unchanged, with no substantive new threat or requirement added.
- 35% rewrittenRisks Related to Our Business and the Industry in Which We Operate
A substantial portion of our revenue is derived from a few customers. If we were to lose a key customer, it would have a material adverse effect on our business, financial condition, and results of operations
The largest customer’s share rose from 75% to 78%, top-three concentration fell from 94% to 92%, and commitments extended through 2028.
All 22 risk factors
Headings as the filing states them, in filing order.
Risks Related to Our Business and the Industry in Which We Operate
- 01A substantial portion of our revenue is derived from a few customers. If we were to lose a key customer, it would have a material adverse effect on our business, financial condition, and results of operations35% rewritten
- 02A substantial portion of our business is derived from our core business area that, if not serviced properly, may result in a material adverse impact upon our business, financial condition, and results of operations
- 03Our customers may cancel or reduce their orders, change production quantities, or delay production, any of which would reduce our sales and adversely affect our results of operations
- 04In recent years, we have launched several new medical device products and our estimates of warranty claims are based largely on our previous history from similar legacy products. If actual warranty claims exceed our estimates, it could have an adverse effect on our results of operations and financial condition
- 05We face significant competition from a number of different sources, which could negatively impact our results of operations
- 06The industry in which we operate is subject to significant technological change and any failure or delay in addressing such change could adversely affect our competitive position or could make our current products obsolete
- 07We rely heavily on our proprietary technology, which, if not properly protected or if deemed invalid, could have a material adverse effect on our business, financial condition, and results of operations
- 08If our technology infrastructure is compromised, damaged or interrupted by a cybersecurity incident, data security breach or other security problems, our results of operations and financial condition could be adversely affected
- 09Our ability to make payments on, and to refinance, our debt obligations and to fund capital expenditures, will depend on our ability to generate cash in the future, which, in turn, is subject to general economic, financial, competitive, regulatory and other factors, many of which are beyond our control
- 10Our cash and cash equivalents may be exposed to banking institution risk
- 11Our operations are dependent upon our key personnel. If such personnel were to leave unexpectedly, we may not be able to execute our business plan
- 12We may not be able to successfully integrate our business acquisitions, which could adversely affect our business, financial condition, and results of operations
- 13We have experienced operating losses in the past. Our ability to achieve or sustain profitability is based on a number of factors, many of which are out of our control, including the material costs for our products and the demand for our products
Risks Related to Ownership of Our Common Stock
- 14Our quarterly results can fluctuate significantly from quarter to quarter, which may negatively impact the price of our shares and/or cause significant variances in the prices at which our shares trade
Regulatory & Compliance Risks
- 15Our operations are subject to a number of complex government regulations, the violation of which could have a material adverse effect on our business
- 16We continually face the possibility of litigation as either a plaintiff or a defendant. It is not reasonably possible to estimate the awards or damages, or the range of awards or damages, if any, that we might incur in connection with such litigation
- 17The agreements governing our various debt obligations impose restrictions on our business and could adversely affect our ability to undertake certain corporate actions
- 18The agreements governing our debt obligations also require us to comply with a number of financial ratios, borrowing base requirements and additional covenants
- 19We are subject to changes in and interpretations of financial accounting matters that govern the measurement of our performance, compliance with which could be costly and time-consuming67% rewritten
- 20Our acquisition of APM may increase our exposure to complex export control and government contracting requirements, the violation of which could have a material adverse effect on our businessNew
General Risks
- 21The global economic environment may impact our business, financial condition, and results of operations
- 22Tariffs could have a negative effect on our business, results of operations, financial condition, and liquidity
Other Pro Dex 10-Ks
- FY2025 10-K risk factors23 risks1 new3 reworded
Customer concentration intensified, with the top three customers rising to 94% of sales and the largest customer reaching 75%.
Filed Sep 04, 2025 - FY2024 10-K risk factors22 risks
Concentration risk is extremely high, with the top three customers generating 88% of fiscal 2024 sales. Internal control weaknesses in inventory accounting and investment valuation persist. Operations depend heavily on medical device sales and a single financial institution for cash.
Filed Sep 05, 2024
About this page
The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.